eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hepatitis c |
| Comorbidity | |hepatocellular carcinoma |
| Sentences | 115 |
| PubMedID- 24703510 | Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis c virus infection. |
| PubMedID- 24462733 | A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis c and cirrhosis. |
| PubMedID- 22555181 | Background: the extent of the effect of antiviral therapy and its predictors in preventing hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c (chc) or b (chb) remain unclear. |
| PubMedID- 24677195 | hepatocellular carcinoma screening in patients with compensated hepatitis c virus (hcv)-related cirrhosis aware of their hcv status improves survival: a modeling approach. |
| PubMedID- 21499248 | To identify the genetic susceptibility factor(s) for hepatitis c virus-induced hepatocellular carcinoma (hcv-induced hcc), we conducted a genome-wide association study using 432,703 autosomal snps in 721 individuals with hcv-induced hcc (cases) and 2,890 hcv-negative controls of japanese origin. |
| PubMedID- 24081938 | Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis c virus infection: further evidence is warranted. |
| PubMedID- 22066022 | Serum microrna-21 as marker for necroinflammation in hepatitis c patients with and without hepatocellular carcinoma. |
| PubMedID- 23404391 | Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis c: report of a case. |
| PubMedID- 21129375 | Background & aims: interferon reportedly decreases the incidence of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 26519622 | The updated model: an adjusted serum alpha-fetoprotein-based algorithm for hepatocellular carcinoma detection with hepatitis c virus-related cirrhosis. |
| PubMedID- 24632756 | The serum level of vegf has potential to be a useful predictor of the presence of hepatocellular carcinoma in patients with hepatitis c virus (hcv)-related liver cirrhosis, while serum levels of afp and vegf can predict tumor type and vascular invasion, respectively25. |
| PubMedID- 21253791 | Several noncurative treatments also appear to reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 23564522 | The effects of interferon (ifn) treatment and the post-ifn treatment alpha-fetoprotein (afp) levels on risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc) are unknown. |
| PubMedID- 22439008 | [10] stated that phlebotomy therapy may potentially lower the risk of progression to hepatocellular carcinoma (hcc) in patients with hepatitis c virus infection. |
| PubMedID- 22911171 | Methods: thirty-eight patients who underwent hepatectomy for hepatocellular carcinoma (hcc) with hepatitis c virus infection were included. |
| PubMedID- 23860735 | Genetic variation near interleukin 28b and the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 20981260 | A 73-year-old man with a history of hepatocellular carcinoma associated with hepatitis c virus-related cirrhosis was referred to the department of urology because a thickened wall of the urinary bladder was incidentally detected by computed tomography (ct). |
| PubMedID- 22879825 | hepatocellular carcinoma complicates 5% of the chronic hepatitis c cases [1][2]. |
| PubMedID- 20616578 | Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis c virus. |
| PubMedID- 22096937 | [antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related chronic hepatitis and cirrhosis]. |
| PubMedID- 21286221 | A 72-year-old japanese man underwent partial resection of the liver for hepatocellular carcinoma associated with hepatitis c viral infection. |
| PubMedID- 23602201 | High tumor necrosis factor-alpha/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 23463401 | hepatocellular carcinoma in patients with chronic hepatitis c virus infection in the asia-pacific region. |
| PubMedID- 24367218 | Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis c virus. |
| PubMedID- 25469280 | Dm with insulin resistance is a risk factor for hepatocellular carcinoma (hcc) in patients with hepatitis c virus (hcv) infection. |
| PubMedID- 26424404 | Background: end-stage liver disease and hepatocellular carcinoma due to hepatitis c virus (hcv) co-infection are increasingly common causes of death among hiv-infected individuals. |
| PubMedID- 24409059 | Latent hepatitis b is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 23065464 | Data on the safety and efficacy of combination therapy in chronic hepatitis c patients with hepatocellular carcinoma (hcc) is scarce and even more so in hiv/hcv co-infected subjects. |
| PubMedID- 22588449 | Skull metastasis from hepatocellular carcinoma with hepatitis c. |
| PubMedID- 22966320 | Development of hepatocellular carcinoma in patients with chronic hepatitis c more than 10 years after sustained virological response to interferon therapy. |
| PubMedID- 25559606 | The effect of hiv viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis c and hiv coinfection. |
| PubMedID- 26305067 | A variant in pnpla3 associated with fibrosis progression but not hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 22419005 | Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 21963516 | To identify the genetic susceptibility factor(s) for hepatitis c virus-induced hepatocellular carcinoma (hcv-induced hcc), we conducted a genome-wide association study using 432,703 autosomal snps in 721 individuals with hcv-induced hcc (cases) and 2890 hcv-negative controls of japanese origin. |
| PubMedID- 25912838 | We assessed the effects of hvpg and svr on the risk of liver decompensation, hepatocellular carcinoma, and/or death in patients with hepatitis c-related cirrhosis. |
| PubMedID- 21374690 | Previous studies have suggested that prior exposure to hepatitis b virus (hbv) infection may increase the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 23395693 | Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis c: further evidence in decompensation cirrhosis. |
| PubMedID- 23426277 | Association of interleukin-28b genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis c. |
| PubMedID- 23701091 | Objective: the objective of our study was to describe the cross-sectional imaging appearance of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of advanced fibrosis and cirrhosis. |
| PubMedID- 21610221 | Background: this study explores the influence of two functional genetic polymorphisms in the regulated on activation in normal t-cell expressed and secreted(rantes) promoter on the risk of hepatocellular carcinoma (hcc) occurrence in patients with alcoholic or hepatitis c virus (hcv)-related cirrhosis. |
| PubMedID- 24179611 | Chemoprevention of hepatocellular carcinoma in patients with hepatitis c virus related cirrhosis. |
| PubMedID- 23547582 | Screening for hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 23509319 | Statins and the risk of hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 22695885 | Background: there is limited literature on hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of cirrhosis. |
| PubMedID- 26140089 | Aim: to evaluate the downstaging rates in hepatitis c virus-patients with hepatocellular carcinoma (hcc), treated with degradable starch microspheres transcatheter arterial chemoembolization (dsm-tace), to reach new-milan-criteria (nmc) for transplantation. |
| PubMedID- 21766498 | Purpose: the aim of this study was to compare patients with hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection with patients with liver cirrhosis associated with hcv virus infection. |
| PubMedID- 22410057 | The primary liver diseases included hepatitis b virus (n=2), alcoholic liver cirrhosis (n=2), cryptogenic liver disease (n=1), and hepatitis c virus with hepatocellular carcinoma (n=1). |
| PubMedID- 22004425 | Genetic risk of hepatocellular carcinoma in patients with hepatitis c virus: a case control study. |
| PubMedID- 24393884 | Case 1 involved a 63-year-old woman who had multiple hepatocellular carcinomas (hcc) associated with hepatitis c virus infection. |
| PubMedID- 26045707 | Conclusions: sustained virological response can reduce all-cause mortality and the incidence of hepatocellular carcinoma of patients with hepatitis c. |